Quantum Leap Healthcare Collaborative
Non-Profit & Charitable Organizations · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
499 Illinois St Ste 200, San Francisco, ...Phone Number
(855) 866-0505Website
www.quantumleaphealth.orgRevenue
<$5 MillionIndustry
About Quantum Leap Healthcare Collaborative
Quantum Leap Healthcare Collaborative Org Chart
Is Quantum Leap Healthcare Collaborative your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Quantum Leap Healthcare Collaborative has new funding data
Earning: See what the market has to say on Quantum Leap Healthcare Collaborative recently announced quarterly report
Check out if Quantum Leap Healthcare Collaborative is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Quantum Leap Healthcare Collaborative launches new products
Click to see if Quantum Leap Healthcare Collaborative had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Quantum Leap Healthcare Collaborative
Website visits: Recent activity has been detected on your website
Check if Quantum Leap Healthcare Collaborative has recently received funding, and reach out quickly before it becomes old news!
Quantum Leap Healthcare Collaborative, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Quantum Leap Healthcare Collaborative
Find more new buyers
Compare Similar Companies to Quantum Leap Healthcare Collaborative
Compare insights from companies similar to Quantum Leap Healthcare Collaborative, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Quantum Leap Healthcare C...
Company Profile Activity
Activity Insights
Quantum Leap Healthcare Collaborative is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Quantum Leap Healthcare Collaborative is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Quantum Leap Healthcare Collaborative.
Quantum Leap Healthcare Collaborative Tech Stack
A closer look at the technologies used by Quantum Leap Healthcare Collaborative
Most Recent Scoops
Quantum Leap Healthcare Collaborative News & Media
Evinova and Quantum Leap Healthcare Partner to Incorporate Real-Time Remote Patient Monitoring into Breast Cancer Platform Trial
Evinova’s Digital Solution Will be Used by Study Sites to Monitor Patients Enrolled in Quantum Leap’s I-SPY 2.2 at Risk of Developing Interstitial Lung Disease Evinova’s Digital Solution Will be Used by Study Sites to Monitor Patients Enrolled in Quantum Leap’s I-SPY 2.2 at Risk of Developing Interstitial Lung DiseaseQuantum Leap Healthcare Collaborative Announces Completion of Datopotamab Deruxtecan and Datopotamab Deruxtecan + Durvalumab Arms in the I-SPY2 Trial for Stage 2/3 Neoadjuvant Breast Cancer
San Francisco, CA, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Quantum Leap Healthcare Collaborative (QLHC), the sponsor and operator of the I-SPY 2 Trial, announces the completion of enrollment for two arms of the I-SPY 2 Trial. The goal was to evaluate the safety and efficacy of datopotamab deruxtecan as single agent therapy or in combination durvalumab.Sermonix Pharmaceuticals’ Lasofoxifene Is Well Tolerated, Demonstrates Promising Ki67 Suppression in Phase 2 I-SPY 2 Arm Evaluating Therapy in Neoadjuvant Breast Cancer Setting
COLUMBUS, Ohio, and SAN FRANCISCO, Nov. 02, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC), and Quantum Leap Healthcare Collaborative™ today broadly announced that in the Phase 2 clinical trial evaluating lasofoxifene as a neoadjuvant endocrine therapy in molecularly selected HR+/HER2-, locally advanced breast cancer, the investigational drug was well tolerSecond generation of I-SPY 2 TRIAL design is driving the “precise” in precision medicine
Groundbreaking I-SPY 2.2 TRIAL, an innovative trial model Revolutionizing the Treatment of Early Stage, High-Risk Breast Cancer Groundbreaking I-SPY 2.2 TRIAL, an innovative trial model Revolutionizing the Treatment of Early Stage, High-Risk Breast Cancer
Top Non-Profit & Charitable Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Quantum Leap Healthcare Collaborative
Quantum Leap Healthcare Collaborative is a 501C(3) charitable organization established in 2005 as a collaboration between medical researchers at University of California, San Francisco and Silicon Valley entrepreneurs. The company's mission is to integrate high-impact research with clinical processes and systems technology, resulting in improved da... Read More